AusarHerbs sold Corona Destroyer Tea with COVID-19 prevention and reversal claims as an unapproved, misbranded drug.
What happened
FDA reviewed ausarherbs.com on December 17, 2020, and FTC reviewed it on December 21, 2020. The site sold “Corona Destroyer Tea” in “Prevention” and “Reversal” options and claimed it would prevent or destroy COVID-19, reverse it in 7 days, and clear symptoms in 3 days. FDA cited it as an unapproved new drug and a misbranded drug.
What FDA found
The company sold a product as a new drug without FDA approval.
section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)The product was misbranded because its labeling made COVID-19 drug claims.
section 502 of the FD&C Act, 21 U.S.C. § 352The company introduced the product into interstate commerce despite these violations.
sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)The company advertised that the tea could prevent, treat, or cure COVID-19 without competent and reliable scientific evidence.
FTC Act, 15 U.S.C. 41 et seq.
What FDA wants
Immediately stop selling any unapproved or unauthorized products claimed to prevent, treat, diagnose, or cure COVID-19. Within 48 hours, email FDA and FTC with the specific steps taken and documentation; if unable to act completely, explain the delay and when you will comply.
Who should pay attention
- herbal and tea brands making health claims
- online sellers of COVID-19-related products
- retailers or marketplaces listing unapproved disease treatments
This is a summary. Read the original letter on fda.gov.